Streetbeat News

Stock Prices

VTS

Vitesse Energy Inc (NYSE:VTS) has acquired additional oil and gas stakes in the Williston Basin of North Dakota, leading to a $50 million expenditure in Q3 and Q4 FY23. As a result, VTS has raised its FY23 production guidance and capital expenditure. The company also provided preliminary FY24 guidance and added oil swaps for Q4 FY23 and FY24. VTS shares are trading higher by 6.56% at $23.05.

Portfolio Pulse from Lekha Gupta

October 09, 2023 | 3:26 pm

ADBE

AMZN

GOOG

MSFT

Tech giants Microsoft, Google, and Adobe are facing challenges in monetizing generative AI tools due to high operational costs. Microsoft reportedly incurred losses on one of its AI products and plans to charge an additional fee for its upcoming AI software upgrade. Google is also adopting a similar strategy. Adobe introduced a credit system for its AI image generator, Firefly, to manage costs. Amazon Web Services CEO noted the industry's dissatisfaction with the expenses of running AI models.

Portfolio Pulse from Anusuya Lahiri

October 09, 2023 | 3:24 pm

ANF

SMCI

SPY

VKTX

The article discusses a strategy for beating the market while hedging, which involves buying and hedging a handful of promising stocks that are relatively inexpensive to hedge. The process involves estimating potential returns, calculating the least expensive way of hedging each security, subtracting the hedging cost from the estimated returns, and buying and hedging the top names. A portfolio created using this strategy, which included Abercrombie & Fitch, Inc. (ANF), Super Micro Computer, Inc. (SMCI), and Viking Therapeutics,Inc. (VKTX), was up 23.28% over six months, compared to 5.18% for the SPDR S&P 500 Trust ETF (SPY).

Portfolio Pulse from dpinsen@yahoo.com

October 09, 2023 | 3:16 pm

ALNY

The FDA has issued a Complete Response Letter (CRL) to Alnylam Pharmaceuticals Inc's supplemental New Drug Application for patisiran for cardiomyopathy of transthyretin-mediated amyloidosis. The FDA questioned the drug's efficacy, stating that the clinical meaningfulness of patisiran's treatment effects had not been established. As a result, Alnylam will no longer pursue an expanded indication for patisiran in the U.S. Alnylam's stock is down 8.68% following the news.

Portfolio Pulse from Vandana Singh

October 09, 2023 | 3:05 pm

CVE

Cenovus Energy (NYSE:CVE) has outperformed the market over the past 5 years, producing an average annual return of 18.37%. If an investor had bought $1000 of CVE stock 5 years ago, it would be worth $2,272.33 today. The company currently has a market capitalization of $38.03 billion.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 3:01 pm

EG

In the last quarter, Everest Group (NYSE:EG) received six analyst ratings, all of which were bullish. The company's average 12-month price target is $435.67, with a high of $452.00 and a low of $408.00. This average price target has increased by 2.63% over the past month.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 3:00 pm

HUM

Over the past 3 months, 12 analysts have published their opinion on Humana (NYSE:HUM) stock. The analysts have an average price target of $590.75 versus the current price of Humana at $497.51, implying upside. This average price target has increased by 0.62% over the past month.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 3:00 pm

PLTR

Shares of Palantir Technologies Inc (NYSE:PLTR) are trading higher amid conflict in the Middle East. The company provides software for security and surveillance purposes, and in a conflict situation, there might be a heightened focus on monitoring and analyzing data related to security threats, which could lead to increased demand for Palantir's products. Palantir also has contracts with various government agencies and defense organizations around the world, which may have an increased need for Palantir's software in times of conflict.

Portfolio Pulse from Henry Khederian

October 09, 2023 | 3:00 pm

BCHUSD

Bitcoin Cash's (CRYPTO: BCH) price has decreased by 5.58% over the past 24 hours to $216.51, continuing its downward trend over the past week of -14.0%. The trading volume for the coin has tumbled 66.0% over the past week while the circulating supply of the coin has risen 1.6%. The current market cap ranking for BCH is #17 at $4.23 billion.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 3:00 pm

LII

Over the last quarter, Lennox Intl (NYSE:LII) has received 1 bullish, 3 somewhat bullish, and 8 indifferent analyst ratings. The average 12-month price target for the company, according to 12 analysts, is $382.5, with a high of $455.00 and a low of $327.00. This average price target has increased by 11.84% over the past month.

Portfolio Pulse from Benzinga Insights

October 09, 2023 | 3:00 pm